CDD clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • International CDKL5 Clinical Research Network

    open to eligible people ages 1 month to 100 years

    Pathogenic variants in the Cyclin-dependent kinase like 5 (CDKL5) gene cause CDKL5 deficiency disorder (CDD, MIM 300672, 105830), a severe developmental and epileptic encephalopathy associated with cognitive and motor impairments and cortical visual …

    at UCLA

Our lead scientists for CDD research studies include .

Last updated: